
The XII Medical CEO has spent a career in the unglamorous middle of medical invention - where patents, payment, teams and patient access must eventually agree.

He built TearScience from a treatment idea into a company acquired by Johnson & Johnson. Then the engineer returned to the same tiny surface with a new question: can an eye drop learn to stay put?